genetic predisposition

Causal effects of Epstein-Barr virus antibodies on autoimmune neuroinflammatory diseases: A generalised summary data-based Mendelian randomisation study

Study Overview The research investigates the complicated relationship between Epstein-Barr virus (EBV) antibodies and various autoimmune neuroinflammatory disorders. Autoimmune diseases, […]

Causal effects of Epstein-Barr virus antibodies on autoimmune neuroinflammatory diseases: A generalised summary data-based Mendelian randomisation study Read Post »

Mechanisms underlying DEHP/MEHP-induced toxicity in multiple sclerosis: An integrated analysis combining network toxicology, bioinformatics, and in vivo experimental validation

Study Overview The investigation into the effects of DEHP (di(2-ethylhexyl) phthalate) and its metabolite MEHP (mono(2-ethylhexyl) phthalate) on multiple sclerosis

Mechanisms underlying DEHP/MEHP-induced toxicity in multiple sclerosis: An integrated analysis combining network toxicology, bioinformatics, and in vivo experimental validation Read Post »

Updates on the Acute and Maintenance Management of Optic Neuritis Including Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Glycoprotein Antibody Disease

Pathophysiology of Optic Neuritis Optic neuritis primarily stems from the inflammatory demyelination of the optic nerve, a vital structure responsible

Updates on the Acute and Maintenance Management of Optic Neuritis Including Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Glycoprotein Antibody Disease Read Post »

Evolution of Nerve Conduction Demyelinating Parameters Between Baseline and Treatment Cessation May Not Be Predictive of Relapse in IVIg-Responsive CIDP Patients

Demyelinating Parameters and Relapse Risk In the context of chronic inflammatory demyelinating polyneuropathy (CIDP), the assessment of nerve conduction parameters

Evolution of Nerve Conduction Demyelinating Parameters Between Baseline and Treatment Cessation May Not Be Predictive of Relapse in IVIg-Responsive CIDP Patients Read Post »

Scroll to Top